{"schema_version":"secwatch.filing_event.v1","accession":"0000055529-24-000027","form_type":"8-K","ticker":"KEQU","cik":"0000055529","company_name":"KEWAUNEE SCIENTIFIC CORP /DE/","filed_at":"2024-09-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.572710+00:00","generated_at":"2026-05-31T05:31:21.262477+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Kewaunee Scientific Q1 FY2025 sales down 2.9%, EPS $0.74 vs $0.86, backlog up 13%","bullets":["Sales $48.4M, down 2.9% YoY; diluted EPS $0.74 vs $0.86 in prior year quarter.","Domestic net earnings rose to $2.9M from $2.7M; International sales fell 10.7% due to India site delays.","Order backlog grew to $159.4M from $140.8M a year ago (+13%).","Adjusted EBITDA (excl. professional fees) $4.1M; professional fees unrelated to core business increased.","Management sees strong backlog and quoting activity for another strong year."],"urls":{"canonical":"https://secwatch.observer/filing/0000055529-24-000027","json":"https://secwatch.observer/filing/0000055529-24-000027.json","markdown":"https://secwatch.observer/filing/0000055529-24-000027.md","text":"https://secwatch.observer/filing/0000055529-24-000027.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/55529/000005552924000027/0000055529-24-000027-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/55529/000005552924000027/kequ-20240911.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T05:31:21.262477+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}